罗斯多宁B通过直接向NLRP3来缓解炎症性疾病
Yanqing Yang1,2,3, Didi Liu1,2, Hairuo Cao1,2
1Department of Clinical Laboratory, The First Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui, China.
概括
来自Isodon植物的天然化合物称为二烯可以抑制NLRP3炎症酶. 罗斯多宁B通过阻断炎症酶激活,显示出强大的潜力,作为治疗炎症疾病的疗法.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 自然产品 化学 化学
背景情况:
- 异常激活NLRP3炎症酶与各种炎症性疾病有关.
- 准NLRP3炎症酶组为这些疾病提供了可行的治疗策略.
研究的目的:
- 来识别具有NLRP3炎症酶抑制活性的伊索登植物天然二烯.
- 研究最强大的抑制剂的作用机制和治疗潜力.
主要方法:
- 对Isodon植物二烯进行NLRP3炎症酶抑制的查.
- 生物化学测试以确定IC50值和相互作用机制.
- 在体内研究使用炎症性疾病的小鼠模型.
主要成果:
- 多重二烯抑制了NLRP3炎症酶激活.
- 罗斯多宁B通过直接结合NLRP3并防止NEK7相互作用,显示出强大的抑制作用 (IC50 = 0.39μM).
- 罗斯多宁B在小鼠模型中显示出显著的治疗效果,包括败血性休克,腹膜炎和结肠炎.
结论:
- 天然二烯,特别是罗斯多宁B,是NLRP3炎症酶的有效抑制剂.
- 这些化合物为NLRP3驱动的炎症性疾病开发新型治疗剂提供了潜力.
相关概念视频
NF-κB-dependent Signaling Pathway
7.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.2K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
115
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
115


